| TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg, T Bivalacqua, ... Cancer research 73 (24), 7162-7167, 2013 | 218 | 2013 |
| 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ... Journal of Nuclear Medicine 56 (7), 1003-1010, 2015 | 185 | 2015 |
| Human NK cells: surface receptors, inhibitory checkpoints, and translational applications S Sivori, P Vacca, G Del Zotto, E Munari, MC Mingari, L Moretta Cellular & molecular immunology 16 (5), 430-441, 2019 | 144 | 2019 |
| Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation D Pende, M Falco, M Vitale, C Cantoni, C Vitale, E Munari, A Bertaina, ... Frontiers in immunology 10, 1179, 2019 | 111 | 2019 |
| Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma SF Faraj, E Munari, G Guner, J Taube, R Anders, J Hicks, A Meeker, ... Urology 85 (3), 703. e1-703. e6, 2015 | 110 | 2015 |
| Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions G Martignoni, S Gobbo, P Camparo, M Brunelli, E Munari, D Segala, ... Modern Pathology 24 (10), 1313-1319, 2011 | 103 | 2011 |
| PD-L1 expression heterogeneity in non–small cell lung cancer: defining criteria for harmonization between biopsy specimens and whole sections E Munari, G Zamboni, G Lunardi, L Marchionni, M Marconi, M Sommaggio, ... Journal of Thoracic Oncology 13 (8), 1113-1120, 2018 | 101 | 2018 |
| PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability E Munari, G Zamboni, M Marconi, M Sommaggio, M Brunelli, G Martignoni, ... Oncotarget 8 (52), 90123, 2017 | 77 | 2017 |
| “Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy E Torlakovic, HJ Lim, J Adam, P Barnes, G Bigras, AWH Chan, ... Modern Pathology 33 (1), 4-17, 2020 | 73 | 2020 |
| Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma E Munari, L Marchionni, A Chitre, M Hayashi, G Martignoni, M Brunelli, ... Human pathology 45 (6), 1130-1138, 2014 | 69 | 2014 |
| Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma E Munari, L Marchionni, A Chitre, M Hayashi, G Martignoni, M Brunelli, ... Human pathology 45 (6), 1130-1138, 2014 | 69 | 2014 |
| PD-L1 assays 22C3 and SP263 are not interchangeable in non–small cell lung cancer when considering clinically relevant cutoffs E Munari, G Rossi, G Zamboni, G Lunardi, M Marconi, M Sommaggio, ... The American journal of surgical pathology 42 (10), 1384-1389, 2018 | 60 | 2018 |
| High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins X Zheng, J Zhuge, SM Bezerra, SF Faraj, E Munari, JT Fallon, XJ Yang, ... Journal of hematology & oncology 7 (1), 1-5, 2014 | 59 | 2014 |
| Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome G Bogina, E Munari, M Brunelli, L Bortesi, M Marconi, M Sommaggio, ... Histopathology 68 (3), 422-432, 2016 | 56 | 2016 |
| Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua D Croxatto, A Micheletti, E Montaldo, P Orecchia, F Loiacono, ... Mucosal immunology 9 (6), 1372-1383, 2016 | 55 | 2016 |
| PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression FR Mariotti, S Petrini, T Ingegnere, N Tumino, F Besi, F Scordamaglia, ... Oncoimmunology 8 (3), 1557030, 2019 | 51 | 2019 |
| Magnitude of PD-1, PD-L1 and T lymphocyte expression on tissue from castration-resistant prostate adenocarcinoma: an exploratory analysis F Massari, C Ciccarese, A Calio, E Munari, L Cima, AB Porcaro, G Novella, ... Targeted oncology 11 (3), 345-351, 2016 | 51 | 2016 |
| Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma AS Baras, N Gandhi, E Munari, S Faraj, L Shultz, L Marchionni, ... PloS one 10 (7), e0131245, 2015 | 48 | 2015 |
| Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes NM Gandhi, A Baras, E Munari, S Faraj, LO Reis, JJ Liu, M Kates, ... Urologic Oncology: Seminars and Original Investigations 33 (5), 204. e1-204. e7, 2015 | 44 | 2015 |
| Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD‐1 receptor N Tumino, S Martini, E Munari, F Scordamaglia, F Besi, FR Mariotti, ... International journal of cancer 145 (6), 1660-1668, 2019 | 42 | 2019 |
Alcides Chaux, M.D.Office of Scientific Research, Norte University, AsunciónEmail verificata su uninorte.edu.py
